Syner-G: Antidepressant action of psychedelics at the glutamatergic interface of brain, behavior and the immune system
July 3, 2025 Natasha L. Mason, Pablo-Alexandre Mallaroni, Attila Szabo et al. preprint
Promising results have emerged in the use of psychedelic drugs for treating depression. Despite multiple neural models attempting to elucidate the acute psychedelic experience, and an increased focus on potential mechanisms driving persistent change, the connections between the acute state and the enduring therapeutic outcomes remain elusive. This targeted review aims to bridge this gap by...